|
Mar 10
|
Roche announces hub for cardiovascular, renal and metabolism research
|
|
Mar 7
|
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
|
|
Mar 5
|
FDA Accepts RHHBY's sNDA for Gazyva in Treating Lupus Nephritis
|
|
Mar 5
|
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
|
|
Mar 5
|
FDA accepts supplemental Biologics License Application for Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis
|
|
Mar 4
|
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
|
|
Mar 4
|
Why Recursion Pharmaceuticals, Inc. (RXRX) Crashed on Monday
|
|
Feb 20
|
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
|
|
Feb 19
|
Q4 2024 Halozyme Therapeutics Inc Earnings Call
|
|
Feb 14
|
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
|
|
Feb 12
|
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
|
|
Feb 12
|
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
|
|
Feb 10
|
Is Roche Holding AG (RHHBY) The Best Annual Dividend Stock To Buy Now?
|
|
Jan 2
|
Innovent and Roche link on lung cancer therapy development
|
|
Dec 29
|
Roche has no plans for job cuts and business is healthy, CEO says
|
|
Oct 1
|
Genentech buys Regor’s CDK inhibitors in $850m deal
|
|
Oct 1
|
Roche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors
|
|
Sep 30
|
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
|
|
Sep 30
|
New weight loss drugs could be developed much faster if Roche gets its way
|
|
Sep 30
|
Roche turns to a startup in search for new breast cancer drugs
|